# active_site_0035

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **A** — Position 2 (Nucleophile)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MCGVLALILANQSSSAANDLHEALYVLQHRGQDAAGIATSTSSGHIHIRKKNGMAADVFQSGARLANLFGSMGIAHLRYPTAGGSANTEAQPFYVNSPYGICFAHNGNLINTVELRRYLDFEIHRHINSDSDSELMLNIFADELSETKKARVNTEDIFNGLSKMYQRCEGAWACTAMLAGFGVIGFRDAYGIRPLVMGSRPSSDGDGLDYMIASESIALDRLGFTNVRDIQPGEAVIVAKGAEPVFCQVAPRKSYTPDLFEYVYFARPDSVIDGISVYQSRQRMGRYLAARLLEVLGPEGIKEIDVVIPVPETSSPAAASVAHALNKPYCAGYIRNPYVFRTFIMPGQATRQKGVRRKLSAVKEEFKNRTILLVDDSIARGTTSREAISMAREAGVKKIIAACCSPEITYPHIYGIDLPSPHEMVAYERDNNDIAQNLGADRIVYQTLEDLQASCAEIARENDFQEPHTFENGVFSGQYVTPVPEGYFALLEKIRGTGRKEALDKSSKRL

[Multiple Choices]
A. Position 2 (Nucleophile)
B. Position 1137 (Proton donor; for dehydratase activity)
C. Position 367 (Proton donor)
D. Position 317 (For beta-ketoacyl synthase activity)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact-sequence-matched UniProt record annotates residue 2 as the active-site nucleophile, consistent with choice A. This is a PROSITE-ProRule computational annotation, not direct experimental evidence for this residue.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has a cysteine at position 2, making it a plausible nucleophile; however, the presence of that residue alone does not establish that it is catalytic.


**Missing item-specific fact**

> The input does not identify the protein's enzyme family or provide an active-site annotation linking Cys2 to nucleophilic catalysis.


**Reason**

> Selecting A as the active-site residue requires a protein-family or site-specific fact not established by the sequence and choices alone. The residue's identity is a useful clue, but not sufficient evidence of its catalytic role.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Only choice A is supported by the matched annotation; choice B also gives a position beyond the supplied sequence length of 510 residues.


### Important caveats

- The site assignment is supported by a computational ProRule annotation; the supplied evidence does not establish direct experimental validation.
- The reviewer-only source information was not part of the evaluated model input and does not make the question reasoning-supported.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a cysteine at position 2, making it a plausible nucleophile; however, the presence of that residue alone does not establish that it is catalytic.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The input does not identify the protein's enzyme family or provide an active-site annotation linking Cys2 to nucleophilic catalysis.",
    "reason": "Selecting A as the active-site residue requires a protein-family or site-specific fact not established by the sequence and choices alone. The residue's identity is a useful clue, but not sufficient evidence of its catalytic role."
  },
  "case_id": "active_site_0035",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact-sequence-matched UniProt record annotates residue 2 as the active-site nucleophile, consistent with choice A. This is a PROSITE-ProRule computational annotation, not direct experimental evidence for this residue."
  },
  "important_caveats": [
    "The site assignment is supported by a computational ProRule annotation; the supplied evidence does not establish direct experimental validation.",
    "The reviewer-only source information was not part of the evaluated model input and does not make the question reasoning-supported."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Only choice A is supported by the matched annotation; choice B also gives a position beyond the supplied sequence length of 510 residues."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0035",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact-sequence-matched UniProt record annotates residue 2 as the active-site nucleophile, consistent with choice A. This is a PROSITE-ProRule computational annotation, not direct experimental evidence for this residue.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has a cysteine at position 2, making it a plausible nucleophile; however, the presence of that residue alone does not establish that it is catalytic.",
    "missing_item_specific_fact": "The input does not identify the protein's enzyme family or provide an active-site annotation linking Cys2 to nucleophilic catalysis.",
    "reason": "Selecting A as the active-site residue requires a protein-family or site-specific fact not established by the sequence and choices alone. The residue's identity is a useful clue, but not sufficient evidence of its catalytic role."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Only choice A is supported by the matched annotation; choice B also gives a position beyond the supplied sequence length of 510 residues."
  },
  "important_caveats": [
    "The site assignment is supported by a computational ProRule annotation; the supplied evidence does not establish direct experimental validation.",
    "The reviewer-only source information was not part of the evaluated model input and does not make the question reasoning-supported."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation (evidence C5/H3) explicitly annotates ACT_SITE at position 2 with note 'Nucleophile', evidenced by PROSITE-ProRule PRU00609 (ECO:0000255, computational/protein-family annotation). The sequence begins 'MC' placing Cys at position 2, consistent with the well-established N-terminal catalytic cysteine nucleophile of type I glutamine amidotransferases. The protein is annotated as EC 2.4.2.14 (phosphoribosylpyrophosphate amidotransferase FrzK). The evidence is computational (pattern-based) rather than direct experimental, but the underlying mechanistic principle (Cys nucleophile in type I amidotransferases) is well-supported by studies of homologous enzymes. Options B (position 1137 exceeds the 510-aa sequence), D (beta-ketoacyl synthase is an unrelated enzyme class), and C (no annotated active site at 367) are all inconsistent with the annotation.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C1](#evidence-c1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 510-aa sequence eliminates option B (position 1137) outright. Option D references 'beta-ketoacyl synthase activity,' a fatty-acid-synthesis enzyme class mechanistically unrelated to amidotransferases, eliminating it by functional mismatch. Between A and C: the sequence contains recognizable type I glutamine amidotransferase motifs (e.g., 'CFAHNG' near residues 36-41), and the N-terminal 'MC' places a cysteine at position 2. In type I glutamine amidotransferases, the N-terminal Cys is the well-characterized nucleophile that attacks the glutamine amide nitrogen. This general mechanistic principle allows selection of A (nucleophile at Cys-2) over C (proton donor at 367), as the primary catalytic residue in this enzyme class is the nucleophilic Cys, not a mid-sequence proton donor.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The question provides a 510-aa sequence from which options B (out-of-range position) and D (wrong enzyme class) are eliminable by basic reasoning. The remaining choice between A and C is resolved by recognizing the type I glutamine amidotransferase fold (supported by sequence motifs like CFAHNG) and applying the general biochemical principle that the N-terminal Cys serves as the catalytic nucleophile in this enzyme family. This is generalizable mechanistic knowledge, not an item-specific lookup.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Option B is physically impossible (position 1137 > 510 aa). Option D names an unrelated enzyme class. Option C (proton donor at 367) is not supported by any annotation and is inconsistent with the primary catalytic mechanism of type I amidotransferases. Only option A aligns with both the annotation and the established mechanism.


### Important caveats

- The active-site annotation carries evidence code ECO:0000255 (PROSITE-ProRule), meaning it is a computational/pattern-based assignment rather than direct experimental mutagenesis or structural evidence for this specific protein.
- The Mg2+ binding sites at positions 313, 375, 376 are annotated by similarity to P00497 (E. coli PurF), indicating transferred annotation for the cofactor-binding domain.
- The reviewer-only evidence was not available to the evaluated model; the reasoning path relies on general biochemical knowledge of type I amidotransferase catalytic mechanisms.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 510-aa sequence eliminates option B (position 1137) outright. Option D references 'beta-ketoacyl synthase activity,' a fatty-acid-synthesis enzyme class mechanistically unrelated to amidotransferases, eliminating it by functional mismatch. Between A and C: the sequence contains recognizable type I glutamine amidotransferase motifs (e.g., 'CFAHNG' near residues 36-41), and the N-terminal 'MC' places a cysteine at position 2. In type I glutamine amidotransferases, the N-terminal Cys is the well-characterized nucleophile that attacks the glutamine amide nitrogen. This general mechanistic principle allows selection of A (nucleophile at Cys-2) over C (proton donor at 367), as the primary catalytic residue in this enzyme class is the nucleophilic Cys, not a mid-sequence proton donor.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The question provides a 510-aa sequence from which options B (out-of-range position) and D (wrong enzyme class) are eliminable by basic reasoning. The remaining choice between A and C is resolved by recognizing the type I glutamine amidotransferase fold (supported by sequence motifs like CFAHNG) and applying the general biochemical principle that the N-terminal Cys serves as the catalytic nucleophile in this enzyme family. This is generalizable mechanistic knowledge, not an item-specific lookup."
  },
  "case_id": "active_site_0035",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C1"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5/H3) explicitly annotates ACT_SITE at position 2 with note 'Nucleophile', evidenced by PROSITE-ProRule PRU00609 (ECO:0000255, computational/protein-family annotation). The sequence begins 'MC' placing Cys at position 2, consistent with the well-established N-terminal catalytic cysteine nucleophile of type I glutamine amidotransferases. The protein is annotated as EC 2.4.2.14 (phosphoribosylpyrophosphate amidotransferase FrzK). The evidence is computational (pattern-based) rather than direct experimental, but the underlying mechanistic principle (Cys nucleophile in type I amidotransferases) is well-supported by studies of homologous enzymes. Options B (position 1137 exceeds the 510-aa sequence), D (beta-ketoacyl synthase is an unrelated enzyme class), and C (no annotated active site at 367) are all inconsistent with the annotation."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000255 (PROSITE-ProRule), meaning it is a computational/pattern-based assignment rather than direct experimental mutagenesis or structural evidence for this specific protein.",
    "The Mg2+ binding sites at positions 313, 375, 376 are annotated by similarity to P00497 (E. coli PurF), indicating transferred annotation for the cofactor-binding domain.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning path relies on general biochemical knowledge of type I amidotransferase catalytic mechanisms."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option B is physically impossible (position 1137 > 510 aa). Option D names an unrelated enzyme class. Option C (proton donor at 367) is not supported by any annotation and is inconsistent with the primary catalytic mechanism of type I amidotransferases. Only option A aligns with both the annotation and the established mechanism."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0035",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5/H3) explicitly annotates ACT_SITE at position 2 with note 'Nucleophile', evidenced by PROSITE-ProRule PRU00609 (ECO:0000255, computational/protein-family annotation). The sequence begins 'MC' placing Cys at position 2, consistent with the well-established N-terminal catalytic cysteine nucleophile of type I glutamine amidotransferases. The protein is annotated as EC 2.4.2.14 (phosphoribosylpyrophosphate amidotransferase FrzK). The evidence is computational (pattern-based) rather than direct experimental, but the underlying mechanistic principle (Cys nucleophile in type I amidotransferases) is well-supported by studies of homologous enzymes. Options B (position 1137 exceeds the 510-aa sequence), D (beta-ketoacyl synthase is an unrelated enzyme class), and C (no annotated active site at 367) are all inconsistent with the annotation.",
    "evidence_ids": ["C5", "H3", "C4", "C1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 510-aa sequence eliminates option B (position 1137) outright. Option D references 'beta-ketoacyl synthase activity,' a fatty-acid-synthesis enzyme class mechanistically unrelated to amidotransferases, eliminating it by functional mismatch. Between A and C: the sequence contains recognizable type I glutamine amidotransferase motifs (e.g., 'CFAHNG' near residues 36-41), and the N-terminal 'MC' places a cysteine at position 2. In type I glutamine amidotransferases, the N-terminal Cys is the well-characterized nucleophile that attacks the glutamine amide nitrogen. This general mechanistic principle allows selection of A (nucleophile at Cys-2) over C (proton donor at 367), as the primary catalytic residue in this enzyme class is the nucleophilic Cys, not a mid-sequence proton donor.",
    "missing_item_specific_fact": "",
    "reason": "The question provides a 510-aa sequence from which options B (out-of-range position) and D (wrong enzyme class) are eliminable by basic reasoning. The remaining choice between A and C is resolved by recognizing the type I glutamine amidotransferase fold (supported by sequence motifs like CFAHNG) and applying the general biochemical principle that the N-terminal Cys serves as the catalytic nucleophile in this enzyme family. This is generalizable mechanistic knowledge, not an item-specific lookup."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option B is physically impossible (position 1137 > 510 aa). Option D names an unrelated enzyme class. Option C (proton donor at 367) is not supported by any annotation and is inconsistent with the primary catalytic mechanism of type I amidotransferases. Only option A aligns with both the annotation and the established mechanism."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000255 (PROSITE-ProRule), meaning it is a computational/pattern-based assignment rather than direct experimental mutagenesis or structural evidence for this specific protein.",
    "The Mg2+ binding sites at positions 313, 375, 376 are annotated by similarity to P00497 (E. coli PurF), indicating transferred annotation for the cofactor-binding domain.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning path relies on general biochemical knowledge of type I amidotransferase catalytic mechanisms."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8J1U7` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 16. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1U7.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:51.826168+00:00.  

```json
"A0A7T8J1U7"
```

Source SHA-256: `56665e1cd9e3380e3faeac05a356479129623641a0ef275c9308eeccf948063d`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1U7.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:51.826168+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis clusters protein K"}},{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Glutamine phosphoribosylpyrophosphate amidotransferase"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"2.4.2.14"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Phosphoribosylpyrophosphate amidotransferase FrzK"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"ATase FrzK"}]}}
```

Source SHA-256: `56665e1cd9e3380e3faeac05a356479129623641a0ef275c9308eeccf948063d`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1U7.json)  
**Locator:** `/features/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:51.826168+00:00.  

```json
{"description":"Nucleophile","evidences":[{"evidenceCode":"ECO:0000255","id":"PRU00609","source":"PROSITE-ProRule"}],"location":{"end":{"modifier":"EXACT","value":2},"start":{"modifier":"EXACT","value":2}},"type":"Active site"}
```

Source SHA-256: `56665e1cd9e3380e3faeac05a356479129623641a0ef275c9308eeccf948063d`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1U7?format=txt&versions=16)  
**Locator:** `lines 99-101`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 16 / 1.  
**Retrieved:** 2026-11-02T04:25:55.036238+00:00.  

```text
FT   ACT_SITE        2
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00609"
```

Source SHA-256: `578ee5dbb88bc40f60a644a1dc0fae09acdb5d05f79fe55109621fabea2329a5`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 35. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
